SEARCH

SEARCH BY CITATION

References

  • 1
    Larsen PL, Tos M. Origin and structure of nasal polyps. In: MygindN, LildholdtT, editors. Nasal polyposis an inflammatory disease and its treatment. Copenhagen: Munksgaard, 1997: 1730.
  • 2
    Widal MF, Abrani P, Lermoyez J. Anaphylaxie et idiosyncrasie. Presse Med 1922;30: 189192.
  • 3
    Szczeklik A, Nizankowska E, Duplaga M. Natural history of aspirin-induced asthma. AIANE Investigators. European Network on Aspirin-induced Asthma. Eur Respir J 2000;16: 432436.
  • 4
    Demoly P, Crampette L, Daures JP. National survey on the management of rhinopathies in asthma patients by French pulmonologists in everyday practice. Allergy 2003;58: 233238.
  • 5
    Gerth van Wijk R. Quality of life, should we bother? Allergy 2003;58: 284286.
  • 6
    Gerth van Wijk R. Allergy: a global problem quality of life. Allergy 2002;57: 10971110.
  • 7
    Baiardini I, Pasquali M, Giardini A, Specchia C, Passalacqua G, Venturi S et al. Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy 2003;58: 289294.
  • 8
    Ware JE, Sherbourne CD. The MOS 36-item short form health survey: I. Conceptual framework and item selection. Med Care 1992;30: 473483.
  • 9
    Alonso J, Prieto L, Anto JM. The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results. Med Clin (Barc) 1995;104: 771776.
  • 10
    Alonso J, Regidor E, Barrio G, Prieto L, Rodriguez C, De La Fuente L. Population reference values of the Spanish version of the Health Questionnaire SF-36. Med Clin (Barc) 1998;111: 410416.
  • 11
    Alonso J, Prieto L, Ferrer M, Vilagut G, Broquetas JM, Roca J et al. Testing the measurement properties of the Spanish version of the SF-36 Health Survey among male patients with chronic obstructive pulmonary disease. Quality of life in COPD study group. J Clin Epidemiol 1998;51: 10871094.
  • 12
    Mygind N. Advances in the medical treatment of nasal polyps. Allergy 1999;54: 1216.
  • 13
    Bachert C, Hörmann K, Mosges R, Rasp G, Riechelmann H, Müller R et al. An update on the diagnosis and treatment of sinusitis and nasal polyposis. Allergy 2003;58: 176191.
  • 14
    Mullol J, Picado C. Treatment of inflammatory disease of the nose. Eur Respir Mon 2001;10: 165183.
  • 15
    Berggren F, Johansson L. Cost effectiveness of nasal budesonide versus surgical treatment for nasal polyps. Pharmacoeconomics 2003;21: 351356.
  • 16
    Johansen LV, Illum P, Kristensen S, Winther L, Petersen SV, Synnerstad B. The effect of Budesonide (Rhinocort®) in the treatment of small and medium sized nasal polyps. Clin Otolaryngol 1993;18: 524527.
  • 17
    Lund VJ, Mackay I. Staging in rhinosinusitis. Rhinology 1993;31: 183184.
  • 18
    Ware JE, Konsinski M, Keller SD. SF-36 physical and mental health summary scales: a user's manual. Boston, Massachusetts: The Health Institute New England Medical Center, 1994.
  • 19
    Cronbach LJ. Coefficient alpha and internal structure of a test. Psychometrika 1951;16: 297334.
  • 20
    Radenne F, Lamblin C, Vandezande LM, Tillie-Leblond I, Darras J, Tonnel AB et al. Quality of life in nasal polyposis. J Allergy Clin Immunol 1999;104: 7984.
  • 21
    Gliklich RE, Metson R. Effect of sinus surgery on quality of life. Otolaryngol Head Neck Surg 1997;117: 1217.
  • 22
    Winstead W, Barnett S. Impact of endoscopic sinus surgery on global health perception: an outcomes study. Otolaryngol Head Neck Surg 1998;119: 486491.
  • 23
    Durr DG, Desrosiers MY, Dassa C. Quality of life in patients with rhinosinusitis. J Otolaryngol 1999;28: 108111.
  • 24
    Wang PC, Tai CJ, Lin MS, Chu CC, Liang SC. Quality of life in Taiwanese adults with chronic rhino-sinusitis. Qual Life Res 2003;12: 443448.
  • 25
    Failde I, Ramos I. Validity and reliability of the SF-36 health survey questionnaire in patients with coronary artery disease. J Clin Epidemiol 2000;53: 359365.
  • 26
    Espinosa De Los Monteros MJ, Alonso J, Ancochea J, Gonzalez A. Quality of life in asthma: reliability and validity of the short form generic questionnaire (SF-36) applied to the population of asthmatics in a public health area. Arch Bronconeumol 2002;38: 49.
  • 27
    Van Agthoven M, Fokkens WJ, Van De Merwe JP, Marijkevan van Bolhuis E, Uyl-de Groot CA, Busschbach JJ. Quality of life of patients with refractory chronic rhinosinusitis: effects of filgrastim treatment. Am J Rhinol 2001;15: 231237.
  • 28
    Rechtweg JS, Moinuddin R, Houser SM, Mamikoglu B, Corey JP. Quality of life in treatment of acute rhinosinusitis with clarithromycin and amoxicillin/clavulanate. Laryngoscope 2004;114: 806810.
  • 29
    Gliklich RE, Hilinski JM. Longitudinal sensitivity of generic and specific health measures in chronic sinusitis. Qual Life Res 1995;4: 2732.
  • 30
    Van Camp C, Clement PA. Results of oral steroid treatment in nasal polyposis. Rhinology 1994;32: 59.
  • 31
    Holmberg K, Juliusson S, Balder B, Smith DL, Richards DH, Karlsson G. Fluticasone propionate aqueous nasal spray in the treatment of nasal polyposis. Ann Allergy Asthma Immunol 1997;78: 270276.
  • 32
    Nores JM, Avan P, Bonfils P. Medical management of nasal polyposis: a study in a series of 152 consecutive patients. Rhinology 2003;41: 97102.
  • 33
    Stammberger H. Surgical treatment of nasal polyps: past, present, and future. Allergy 1999;54: 711.
  • 34
    Vento SI, Ertama LO, Hytonen ML, Wolff CH, Malmberg CH. Nasal polyposis: clinical course during 20 years. Ann Allergy Asthma Immunol 2000;85: 209214.
  • 35
    Lildholdt T, Fogstrup J, Gammelgaard N, Kortholm B, Ulsoe C. Surgical versus medical treatment of nasal polyps. Acta Otolaryngol 1988;105: 140143.
  • 36
    Blomqvist EH, Lundblad L, Änggard A, Haraldsson PO, Stjärne P. A randomized controlled study evaluating medical treatment versus surgical treatment in addition to medical treatment of nasal polyposis. J Allergy Clin Immunol 2001;107: 224228.
  • 37
    Jankowski R, Bodino C. Evolution of symptoms associated to nasal polyposis following oral steroid treatment and nasalization of the ethmoid – radical ethmoidectomy is functional surgery for NPS. Rhinology 2003;41: 211219.
  • 38
    Jankowski R, Bodino C. Olfaction in patients with nasal polyposis: effects of systemic steroids and radical ethmoidectomy with middle turbinate resection (nasalization). Rhinology 2003;41: 220230.
  • 39
    Lund VJ, Flood J, Sykes AP, Richards DH. Effect of fluticasone in severe polyposis. Arch Otolaryngol Head Neck Surg 1998;124: 513518.
  • 40
    Bonfils P, Nores JM, Halimi P, Avan P. Corticosteroid treatment in nasal polyposis with a three-year follow-up period. Laryngoscope 2003;113: 683687.
  • 41
    Krouse JH. Computed tomography stage, allergy testing, and quality of life in patients with sinusitis. Otolaryngol Head Neck Surg 2000;123: 389392.
  • 42
    Uri N, Cohen-Kerem R, Barzilai G, Greenberg E, Doweck I, Weiler-Ravell D. Functional endoscopic sinus surgery in the treatment of massive polyposis in asthmatic patients. J Laryngol Otol 2002;116: 185189.